Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 4Completed 2Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 6Colonic Neoplasms 4Adenomatous Polyps 2Adenoma 2Signs and Symptoms, Digestive 1Rectal Neoplasms 1Polyps 1Neoplasms 1Lymphoma, B-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Colonoscopy × Clear all
NCT02926209 2019-07-16

Post Market Evaluation of Aer-O-Scope Visualization

GI View Ltd.

Phase NA Terminated
104 enrolled 5 charts

Adenoma, Neoplasms, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡